The combined platform brings together digital slide scanning and AI-driven precision pathology software to accelerate accessible and scalable adoption of precision diagnostics TAMPERE, FI AND ...
AI in Pathology Market OverviewThe global AI in pathology market is undergoing rapid expansion, driven by transformative changes across diagnostic medicine and healthcare technology. The market is ...
ABL Diagnostics accelerates international growth with key public contracts and platform-agnostic microbiology solutions ...
S&P 500 Index attention highlights Charles River Laboratories International, digital pathology expansion, biologics testing ...
Moving from pen and paper to a fully digitalised logistics solution is saving time and money for one of Australia's biggest ...
Leveraging an annualized run-rate baseline of ~1M€ from late 2025, the Company accelerates its strategic rollout of ...
Despite rapid advances in AI, many drug discovery models still struggle to translate computational predictions into clinical ...
Advances in technology are transforming criminal justice, but without safeguards, they can also lead to wrongful convictions ...
Florence 1 Schools just received its grants from The School Foundation for the 2026-2027 school year. Here’s what projects ...
Validation of MMAI in node-positive HR+ breast cancer to determine chemotherapy benefit Concordance analysis between MMAI and ...
The global Clinical Informatics Market size is projected to grow at a CAGR of 16% over the next 5 years. Increasing ...
StockStory.org on MSN
A look back at healthcare providers & services stocks’ Q1 earnings: McKesson (NYSE:MCK) vs the rest of the pack
Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at McKesson (NYSE:MCK) and its peers. The healthcare providers and services ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results